David Solit

85PUBLICATIONS
721CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (85)

|Oct 25, 2026
SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers.

|Oct 20, 2026
Mutational Signatures and Hypermutation Phenotypes Define Bladder Cancers Arising in Waterpipe and Cigarette Smokers.

|Oct 10, 2026
CDKPredict: a clinicogenomic model for risk-adapted therapeutic intervention in breast cancer.

|Oct 08, 2026
Universal Germline Genetic Testing after a Diagnosis of Cancer.

|Sep 10, 2026
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

Pageof 15

Frequent Collaborators

33 joint publications

Michael F Berger

20 joint publications

Nikolaus Schultz

18 joint publications

Hikmat Al-Ahmadie

17 joint publications

Gopakumar V Iyer